speb/financial-data huggingface dataset:
Financial ratios for ALGIR.PA — annual report dated 2022-09-30
Total revenue: 100571568.62745097
Gross profit: 29287254.901960783
Operating income: -1248039.2156862745
Net income: -3579411.7647058824
Capital expenditures: 2017647.0588235294
Operating cash flow: 3522549.019607843
Depreciation & amortization: 7843.137254901961
Net tangible assets: 39623529.4117647
Owner earnings: -5589215.68627451
Return on net tangible assets (%): -14.105799683293746
Buffett classification: The Gruesome
Stock price: 9.77450980392157
Shares outstanding: 986298
Book value: 50509803.92156863
P/B ratio: 0.19086550970496893
Market cap (USD): 9640579.470588235
Debt to equity: 0.30040760869565214
Current ratio: 2.268340957072484
Quick ratio: 1.4685960591133007
Interest coverage ratio: -5.866359447004608
COGS to revenue (%): 70.8791905091487
SG&A to revenue (%): 26.94306074105846
Free cash flow (dilution-adjusted): -130392.15686274509
Buyback yield (%): 0
Retained earnings: 37311764.705882356
Inventory turnover: 3.9987900786448884
Receivables turnover: 4.690795189537702
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -1.9496132935140513
FCF margin (%): -0.12965111178265404
Rule of 40 score: -0.12965111178265404
Financial ratios for ALGIR.PA — annual report dated 2023-09-30
Total revenue: 110792631.57894738
Gross profit: 35852631.57894737
Operating income: 4723157.894736842
Net income: 3132631.5789473685
Capital expenditures: 4102105.263157895
Operating cash flow: 12387368.421052633
Depreciation & amortization: 6783157.894736842
Net tangible assets: 45915789.473684214
Owner earnings: 5813684.2105263155
Return on net tangible assets (%): 12.661623108665749
Capex to operating income (%): 86.85090260753287
Buffett classification: The Gruesome
Stock price: 11.842105263157896
P/E ratio: 3.728445060483871
Shares outstanding: 986298
Book value: 58022105.26315789
P/B ratio: 0.2012999129188513
Market cap (USD): 11679844.736842105
Debt to equity: 0.37961938281235835
Current ratio: 2.6070474713534937
Quick ratio: 1.8564659257344707
Effective tax rate (%): 6.970928415129728
Interest coverage ratio: 10.338709677419354
COGS to revenue (%): 67.63987724815445
Free cash flow (dilution-adjusted): 7717894.736842105
Buyback yield (%): 0
Retained earnings: 43851578.94736842
Inventory turnover: 4.085915977961433
Receivables turnover: 4.779881925522252
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 6.141611574207148
FCF margin (%): 6.966072225969805
Revenue growth (%): 10.16297457719733
Rule of 40 score: 17.129046803167135
Financial ratios for ALGIR.PA — quarterly report dated 2024-09-30
Capital expenditures: 0
Net tangible assets: 48676666.666666664
Buffett classification: The Gruesome
Stock price: 13.166666666666666
Shares outstanding: 986298
Book value: 60853333.33333332
P/B ratio: 0.21340255806310257
Market cap (USD): 12986257
Debt to equity: 0.36862766579024253
Current ratio: 2.5075381047051026
Quick ratio: 1.8104290921139825
Buyback yield (%): 0
Retained earnings: 45895555.55555555
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for ALGIR.PA — annual report dated 2024-09-30
Total revenue: 113147777.77777778
Gross profit: 32867777.777777776
Operating income: 2157777.7777777775
Net income: 977777.7777777778
Capital expenditures: 2580000
Operating cash flow: 12422222.222222222
Depreciation & amortization: 7580000
Net tangible assets: 48676666.666666664
Owner earnings: 5977777.777777778
Return on net tangible assets (%): 12.280581615649753
Capex to operating income (%): 119.56745623069003
Buffett classification: The Gruesome
Stock price: 13.166666666666666
P/E ratio: 13.281399204545455
Shares outstanding: 986298
Book value: 60853333.33333332
P/B ratio: 0.21340255806310257
Market cap (USD): 12986257
Debt to equity: 0.36862766579024253
Current ratio: 2.5075381047051026
Quick ratio: 1.8104290921139825
Effective tax rate (%): 42.55181347150259
Interest coverage ratio: 3.092356687898089
COGS to revenue (%): 70.95145974291242
Free cash flow (dilution-adjusted): 8255555.555555555
Buyback yield (%): 0
Retained earnings: 45895555.55555555
Inventory turnover: 4.292793060424217
Receivables turnover: 5.203259925399826
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 2.7182889616752046
FCF margin (%): 7.296259562224426
Revenue growth (%): 2.1257245768660997
Rule of 40 score: 9.421984139090526
Financial ratios for ALGIR.PA — quarterly report dated 2025-03-31
Capital expenditures: 0
Net tangible assets: 45891304.347826086
Buffett classification: The Gruesome
Stock price: 17.445652173913043
Shares outstanding: 986298
Book value: 57714130.43478261
P/B ratio: 0.29813516582857785
Market cap (USD): 17206611.847826086
Debt to equity: 0.33790986308077664
Current ratio: 2.5271647246972813
Quick ratio: 2.5271647246972813
Buyback yield (%): 0
Retained earnings: 43081521.73913043
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for ALGIR.PA — quarterly report dated 2025-09-30
Capital expenditures: 0
Net tangible assets: 50723529.4117647
Buffett classification: The Gruesome
Stock price: 16.176470588235293
Shares outstanding: 986298
Book value: 63149411.76470589
P/B ratio: 0.25265192726866254
Market cap (USD): 15954820.588235293
Debt to equity: 0.3493675130875421
Current ratio: 2.6857250506287382
Quick ratio: 1.9426835586115951
Buyback yield (%): 0
Retained earnings: 47311764.705882356
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for ALGIR.PA — annual report dated 2025-09-30
Total revenue: 119614117.64705883
Gross profit: 32215294.11764706
Operating income: 1875294.1176470588
Net income: 898823.5294117647
Capital expenditures: 4443529.411764706
Operating cash flow: 6975294.117647059
Depreciation & amortization: 7791764.705882353
Net tangible assets: 50723529.4117647
Owner earnings: 4247058.823529411
Return on net tangible assets (%): 8.372956047779194
Capex to operating income (%): 236.95106649937264
Buffett classification: The Gruesome
Stock price: 16.176470588235293
P/E ratio: 17.750782068062826
Shares outstanding: 986298
Book value: 63149411.76470589
P/B ratio: 0.25265192726866254
Market cap (USD): 15954820.588235293
Debt to equity: 0.3493675130875421
Current ratio: 2.6857250506287382
Quick ratio: 1.9426835586115951
Effective tax rate (%): 36.54485049833887
Interest coverage ratio: 2.3720238095238093
COGS to revenue (%): 73.06731450153434
Free cash flow (dilution-adjusted): 1758823.5294117648
Buyback yield (%): 0
Retained earnings: 47311764.705882356
Inventory turnover: 4.708689864993344
Receivables turnover: 5.16127722219402
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 2.2854357239124825
FCF margin (%): 1.4704146667715792
Revenue growth (%): 5.714950833573545
Rule of 40 score: 7.1853655003451244
Financial ratios for ALLT — annual report dated 2021-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 11.88
Shares outstanding: 48923099
Market cap (USD): 581206416.12
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for ALLT — annual report dated 2022-12-31
Total revenue: 34868465.90909091
Gross profit: 23552840.90909091
Operating income: -9167329.545454545
Net income: -9099431.818181818
Capital expenditures: 1602840.9090909092
Operating cash flow: -9251420.454545455
Depreciation & amortization: 2088636.3636363635
Net tangible assets: 18928693.181818184
Owner earnings: -8613636.363636363
Return on net tangible assets (%): -45.5057107265605
Buffett classification: The Gruesome
Stock price: 3.44
Shares outstanding: 48923099
Book value: 28969602.272727277
P/B ratio: 5.809381122171555
Market cap (USD): 168295460.56
Debt to equity: 0.43831210222313743
Current ratio: 2.5051896833385587
Quick ratio: 2.2863484100922427
Interest coverage ratio: -849.1842105263157
COGS to revenue (%): 32.45231674230265
R&D to revenue (%): 40.57456186805935
SG&A to revenue (%): 53.26429682980683
Free cash flow (dilution-adjusted): -13457954.545454545
Buyback yield (%): 0
Retained earnings: -55973579.54545455
Inventory turnover: 3.0033931533705323
Receivables turnover: 2.5890604564823017
Capitalized R&D asset: 14147727.272727273
ROCI (R&D-adjusted, %): 0.4605445407416224
FCF margin (%): -38.59634828943187
Rule of 40 score: -38.59634828943187
Financial ratios for ALLT — annual report dated 2023-12-31
Total revenue: 25732044.198895026
Gross profit: 14554143.64640884
Operating income: -17937845.303867403
Net income: -17349171.27071823
Capital expenditures: 687569.0607734807
Operating cash flow: -8214364.6408839775
Depreciation & amortization: 2301104.9723756905
Net tangible assets: 4700276.243093923
Owner earnings: -15735635.359116022
Return on net tangible assets (%): -334.78107552159855
Buffett classification: The Gruesome
Stock price: 1.65
Shares outstanding: 48923099
Book value: 13746685.082872927
P/B ratio: 5.872187575648574
Market cap (USD): 80723113.35
Debt to equity: 0.8425537045596126
Current ratio: 2.2815671944782787
Quick ratio: 1.9802578156719448
Interest coverage ratio: -901.8750000000001
COGS to revenue (%): 43.43961352657005
R&D to revenue (%): 41.99141170155663
SG&A to revenue (%): 84.27911969940955
Free cash flow (dilution-adjusted): -11345303.867403315
Buyback yield (%): 0
Retained earnings: -71776519.33701657
Inventory turnover: 3.407781707933299
Receivables turnover: 5.618214716525935
Capitalized R&D asset: 20284225.891511805
ROCI (R&D-adjusted, %): -32.482668228949805
Rosenberg metric: -0.6360524972819456
FCF margin (%): -44.0901771336554
Revenue growth (%): -26.20253421534623
Rule of 40 score: -70.29271134900164
Financial ratios for ALLT — quarterly report dated 2024-09-30
Capital expenditures: 0
Depreciation & amortization: 296486.48648648645
Buffett classification: The Gruesome
Stock price: 2.97
Shares outstanding: 48923099
Market cap (USD): 145301604.03
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for ALLT — quarterly report dated 2024-12-31
Capital expenditures: 0
Depreciation & amortization: 755068.493150685
Buffett classification: The Gruesome
Stock price: 5.95
Shares outstanding: 48923099
Market cap (USD): 291092439.05
Buyback yield (%): 0
Retained earnings: -72794520.5479452
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for ALLT — annual report dated 2024-12-31
Total revenue: 25258904.10958904
Gross profit: 17449315.06849315
Operating income: -1647671.2328767125
Net income: -1607945.2054794522
Capital expenditures: 580000
Operating cash flow: 1322191.7808219178
Depreciation & amortization: 1760000
Net tangible assets: 4841369.863013699
Owner earnings: -427945.20547945215
Return on net tangible assets (%): -8.839341293644958
Buffett classification: The Gruesome
Stock price: 5.95
Shares outstanding: 48923099
Book value: 13646301.369863011
P/B ratio: 21.3312333620932
Market cap (USD): 291092439.05
Debt to equity: 0.9303941054829451
Current ratio: 2.506978037253267
Quick ratio: 2.2675840978593276
COGS to revenue (%): 30.918162590162158
R&D to revenue (%): 28.32257714626607
SG&A to revenue (%): 47.282390585172735
Free cash flow (dilution-adjusted): -912602.7397260275
Buyback yield (%): 0
Retained earnings: -72794520.5479452
Inventory turnover: 3.310300778074556
Receivables turnover: 5.192329353457986
Capitalized R&D asset: 19062239.17732536
ROCI (R&D-adjusted, %): -10.946986437566514
Rosenberg metric: 0.26794121303707547
FCF margin (%): -3.612994197082272
Revenue growth (%): -1.8387194023485436
Rule of 40 score: -5.451713599430816
Financial ratios for ALLT — quarterly report dated 2025-03-31
Total revenue: 6273712.737127371
Gross profit: 4348780.4878048785
Operating income: -192140.9214092141
Net income: -89972.89972899729
Capital expenditures: 76151.76151761517
Operating cash flow: 453929.539295393
Depreciation & amortization: 364769.64769647695
Net tangible assets: 4882113.8211382115
Owner earnings: 198644.98644986446
Buffett classification: The Gruesome
Stock price: 5.71
Shares outstanding: 48923099
Book value: 13550406.50406504
P/B ratio: 20.615683758726828
Market cap (USD): 279350895.29
Debt to equity: 0.9230815383692327
Current ratio: 2.4850700953084988
Quick ratio: 2.268764685693165
COGS to revenue (%): 30.68250539956804
R&D to revenue (%): 25.879049676025918
SG&A to revenue (%): 46.501079913606915
Free cash flow (dilution-adjusted): 111924.11924119241
Buyback yield (%): 0
Retained earnings: -72095392.95392954
Inventory turnover: 0.866959599658245
Receivables turnover: 0.9180314866954832
Capitalized R&D asset: 1623577.2357723578
ROCI (R&D-adjusted, %): 3.0287942909302137
FCF margin (%): 1.7840172786177106
Rule of 40 score: 1.7840172786177106
Financial ratios for ALLT — quarterly report dated 2025-06-30
Total revenue: 7094690.265486726
Gross profit: 5112094.395280235
Operating income: -120058.99705014749
Net income: -498525.07374631264
Capital expenditures: 120353.98230088495
Operating cash flow: 1293215.3392330382
Depreciation & amortization: 316519.1740412979
Net tangible assets: 20024778.761061948
Owner earnings: -302359.8820058997
Return on net tangible assets (%): -1.5099287019032466
Buffett classification: The Gruesome
Stock price: 8.55
Shares outstanding: 48923099
Book value: 29415044.24778761
P/B ratio: 14.220359246322094
Market cap (USD): 418292496.45000005
Debt to equity: 0.06112297802781872
Current ratio: 2.086801654275537
Quick ratio: 1.8834835409146327
COGS to revenue (%): 27.94478400066525
R&D to revenue (%): 30.19001288927695
SG&A to revenue (%): 43.55744043906699
Free cash flow (dilution-adjusted): 745427.7286135694
Buyback yield (%): 0
Inventory turnover: 0.7902410346854792
Receivables turnover: 0.8358006672226856
Capitalized R&D asset: 3229684.6535721994
ROCI (R&D-adjusted, %): 2.110117867251356
Rosenberg metric: 0.47014326799934353
FCF margin (%): 10.506839632447717
Revenue growth (%): 13.08599170473442
Rule of 40 score: 23.592831337182137
Financial ratios for ALLT — quarterly report dated 2025-09-30
Total revenue: 7977341.389728096
Gross profit: 5699697.885196375
Operating income: 649546.827794562
Net income: 853172.2054380665
Capital expenditures: 30211.480362537764
Operating cash flow: 1220845.9214501511
Depreciation & amortization: 252265.86102719032
Net tangible assets: 23471299.09365559
Owner earnings: 1075226.586102719
Return on net tangible assets (%): 4.58102715922255
Capex to operating income (%): 4.651162790697675
Buffett classification: The Great
Stock price: 10.58
P/E ratio: 1955.6357397603954
Shares outstanding: 48923099
Book value: 33088519.63746224
P/B ratio: 15.643080835625392
Market cap (USD): 517606387.42
Debt to equity: 0.057275640732996715
Current ratio: 2.5128285973278683
Quick ratio: 2.2328459385961454
Effective tax rate (%): 6.459092414706856
COGS to revenue (%): 28.551410717667107
R&D to revenue (%): 20.7877295966673
SG&A to revenue (%): 42.51846241242189
Free cash flow (dilution-adjusted): 719637.4622356496
Buyback yield (%): 0
Inventory turnover: 0.5306165540540541
Receivables turnover: 0.8014143498846668
Capitalized R&D asset: 3629153.5416597384
ROCI (R&D-adjusted, %): 1.244333098564428
Rosenberg metric: 0.27433904845279056
FCF margin (%): 9.021018746449537
Revenue growth (%): 12.441009983694011
Rule of 40 score: 21.462028730143548
Financial ratios for ALLT — quarterly report dated 2025-12-31
Total revenue: 8926729.559748428
Gross profit: 6386163.522012578
Operating income: 808176.1006289307
Net income: 912578.6163522012
Capital expenditures: 472955.9748427673
Operating cash flow: 2557861.635220126
Depreciation & amortization: 249685.53459119497
Net tangible assets: 25634276.729559746
Owner earnings: 689308.1761006289
Return on net tangible assets (%): 2.689009654427911
Capex to operating income (%): 58.52140077821012
Buffett classification: The Good
Stock price: 9.83
P/E ratio: 408.50532989437977
Shares outstanding: 48923099
Book value: 35644654.08805031
P/B ratio: 13.491898728545214
Market cap (USD): 480914063.17
Debt to equity: 0.050639611821790914
Current ratio: 2.6501834220403313
Quick ratio: 2.3707033652113063
Effective tax rate (%): 12.379227053140097
COGS to revenue (%): 28.460210659809064
R&D to revenue (%): 20.2733645682883
SG&A to revenue (%): 42.212984816993696
Free cash flow (dilution-adjusted): 1761320.754716981
Buyback yield (%): 0
Retained earnings: -82388364.7798742
Inventory turnover: 0.6129742033383916
Receivables turnover: 1.5113938877648814
Capitalized R&D asset: 3627637.901779311
ROCI (R&D-adjusted, %): 1.735140195512995
Rosenberg metric: 0.41395541225389576
FCF margin (%): 19.730862718850176
Revenue growth (%): 11.901059809760643
Rule of 40 score: 31.63192252861082
Financial ratios for ALLT — annual report dated 2025-12-31
Total revenue: 32073270.44025157
Gross profit: 22815094.33962264
Operating income: 1133333.3333333333
Net income: 1165094.3396226414
Capital expenditures: 721069.1823899371
Operating cash flow: 5594654.088050314
Depreciation & amortization: 1272955.9748427672
Net tangible assets: 25634276.729559746
Owner earnings: 1716981.1320754716
Return on net tangible assets (%): 6.697989376449084
Capex to operating income (%): 63.6237513873474
Buffett classification: The Good
Stock price: 9.83
P/E ratio: 412.7683457167612
Shares outstanding: 48923099
Book value: 35644654.08805031
P/B ratio: 13.491898728545214
Market cap (USD): 480914063.17
Debt to equity: 0.050639611821790914
Current ratio: 2.6501834220403313
Quick ratio: 2.3707033652113063
Effective tax rate (%): 24.96962332928311
Interest coverage ratio: 49.369863013698634
COGS to revenue (%): 28.865706470051872
R&D to revenue (%): 24.01733452295746
SG&A to revenue (%): 43.58338317335503
Free cash flow (dilution-adjusted): 3295597.484276729
Buyback yield (%): 0
Retained earnings: -82388364.7798742
Inventory turnover: 2.233763277693475
Receivables turnover: 5.430358854222128
Capitalized R&D asset: 16062038.342122562
ROCI (R&D-adjusted, %): 0.5083829634617799
Rosenberg metric: 0.75004190945246
FCF margin (%): 10.27521496573294
Revenue growth (%): 26.97807593353027
Rule of 40 score: 37.25329089926321
Financial ratios for AMIF.L — annual report dated 2023-12-31
Total revenue: 18507594.93670886
Gross profit: 8803797.46835443
Operating income: 2503797.46835443
Net income: 221518.98734177215
Capital expenditures: 279746.83544303797
Operating cash flow: 650632.911392405
Depreciation & amortization: 505063.2911392405
Net tangible assets: 4445569.620253164
Owner earnings: 446835.4430379747
Return on net tangible assets (%): 10.051252847380411
Capex to operating income (%): 11.172901921132459
Buffett classification: The Great
Stock price: 0.018860759493670887
P/E ratio: 10.275596664
Shares outstanding: 120686538
Book value: 4555696.202531646
P/B ratio: 0.4996469619894415
Market cap (USD): 2276239.767341772
Debt to equity: 0.21950541817171434
Current ratio: 1.6896809571286142
Quick ratio: 1.6896809571286142
Effective tax rate (%): 78.7363304981774
Interest coverage ratio: 18.314814814814813
COGS to revenue (%): 52.43143423842418
R&D to revenue (%): 4.069489091033445
SG&A to revenue (%): 7.988509677860611
Free cash flow (dilution-adjusted): 370886.0759493671
Buyback yield (%): 0
Retained earnings: -1089873.417721519
Receivables turnover: 5.066181566181566
Capitalized R&D asset: 1086814.9965582478
ROCI (R&D-adjusted, %): 44.68216686257294
Rosenberg metric: 4.799334849153289
FCF margin (%): 2.0039668969290747
Revenue growth (%): 55.290171830452415
Rule of 40 score: 57.29413872738149
Financial ratios for AMIF.L — quarterly report dated 2024-12-31
Capital expenditures: 0
Net tangible assets: 5762500
Buffett classification: The Gruesome
Stock price: 0.018625
Shares outstanding: 120686538
Book value: 5848750
P/B ratio: 0.3843191742252618
Market cap (USD): 2247786.77025
Debt to equity: 0.09873904680487283
Current ratio: 2.3223880597014928
Quick ratio: 2.3223880597014928
Buyback yield (%): 0
Retained earnings: -201250
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for AMIF.L — annual report dated 2024-12-31
Total revenue: 19520000
Gross profit: 9291250
Operating income: 1512500
Net income: 875000
Capital expenditures: 68750
Operating cash flow: 501250
Depreciation & amortization: 507500
Net tangible assets: 5762500
Owner earnings: 1313750
Return on net tangible assets (%): 22.79826464208243
Capex to operating income (%): 4.545454545454546
Buffett classification: The Great
Stock price: 0.018625
P/E ratio: 2.568899166
Shares outstanding: 120686538
Book value: 5848750
P/B ratio: 0.3843191742252618
Market cap (USD): 2247786.77025
Debt to equity: 0.09873904680487283
Current ratio: 2.3223880597014928
Quick ratio: 2.3223880597014928
Effective tax rate (%): 33.523266856600195
Interest coverage ratio: 24.693877551020407
COGS to revenue (%): 52.401383196721305
SG&A to revenue (%): 11.456198770491802
Free cash flow (dilution-adjusted): 432500
Buyback yield (%): 0
Retained earnings: -201250
Receivables turnover: 5.565217391304348
Capitalized R&D asset: 652921.4579838341
ROCI (R&D-adjusted, %): 16.416123519718905
Rosenberg metric: 0.6472058823529416
FCF margin (%): 2.2156762295081966
Revenue growth (%): 5.470214075644624
Rule of 40 score: 7.685890305152821
Financial ratios for AMIF.L — quarterly report dated 2025-06-30
Capital expenditures: 0
Net tangible assets: 9528767.123287672
Buffett classification: The Gruesome
Stock price: 0.02273972602739726
Shares outstanding: 120686538
Book value: 9615068.493150685
P/B ratio: 0.2854247799971506
Market cap (USD): 2744378.8093150686
Debt to equity: 0.05285653226955407
Current ratio: 3.3684210526315788
Quick ratio: 3.3684210526315788
Buyback yield (%): 0
Retained earnings: 2856164.383561644
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for BJDX — annual report dated 2021-12-31
Gross profit: 0
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 81920
Shares outstanding: 1034715
Market cap (USD): 84763852800
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for BJDX — annual report dated 2022-12-31
Total revenue: 249040
Gross profit: 48911
Operating income: -9317776
Net income: -9296948
Capital expenditures: 1199270
Operating cash flow: -7741593
Depreciation & amortization: 306368
Net tangible assets: 11541273
Owner earnings: -10189850
Return on net tangible assets (%): -88.2905204651168
Buffett classification: The Gruesome
Stock price: 12160
Shares outstanding: 1034715
Book value: 11541273
P/B ratio: 1090.186013276005
Market cap (USD): 12582134400
Debt to equity: 0.04268341975794178
Current ratio: 7.186978358229884
Quick ratio: 7.186978358229884
COGS to revenue (%): 80.36018310311597
R&D to revenue (%): 1667.2630902666237
SG&A to revenue (%): 2093.854400899454
Free cash flow (dilution-adjusted): -9373867
Buyback yield (%): 0
Retained earnings: -16997102
Capitalized R&D asset: 4152152
ROCI (R&D-adjusted, %): -40.85079573298586
FCF margin (%): -3764.0005621586893
Rule of 40 score: -3764.0005621586893
Financial ratios for BJDX — annual report dated 2023-12-31
Total revenue: 0
Gross profit: 0
Operating income: -10311217
Net income: -9953888
Capital expenditures: 704166
Operating cash flow: -8313870
Depreciation & amortization: 780955
Net tangible assets: 2894848
Owner earnings: -9877099
Return on net tangible assets (%): -341.19577262778563
Buffett classification: The Gruesome
Stock price: 1952
Shares outstanding: 1034715
Book value: 2894848
P/B ratio: 697.7097519455253
Market cap (USD): 2019763680
Debt to equity: 0.12193282687035727
Current ratio: 1.8182824077341049
Quick ratio: 1.8182824077341049
Free cash flow (dilution-adjusted): -9207281
Buyback yield (%): 0
Retained earnings: -26950990
Capitalized R&D asset: 8496515.84
ROCI (R&D-adjusted, %): -68.01599851619284
Rosenberg metric: -0.011779674732524243
Revenue growth (%): -100
Rule of 40 score: -100
Financial ratios for BJDX — quarterly report dated 2024-09-30
Capital expenditures: 227
Buffett classification: The Gruesome
Stock price: 25.4
Shares outstanding: 1034715
Market cap (USD): 26281761
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for BJDX — annual report dated 2024-12-31
Total revenue: 0
Operating income: -7169616
Net income: -7717794
Capital expenditures: 306783
Operating cash flow: -7820822
Depreciation & amortization: 199097
Net tangible assets: 5729499
Owner earnings: -7825480
Return on net tangible assets (%): -136.58227359844204
Buffett classification: The Gruesome
Stock price: 19.48
Shares outstanding: 1034715
Book value: 5729499
P/B ratio: 3.517977435723438
Market cap (USD): 20156248.2
Debt to equity: 0.0387903026076102
Current ratio: 6.04525721647449
Quick ratio: 6.04525721647449
Interest coverage ratio: -8.711266202364925
Free cash flow (dilution-adjusted): -8147699
Buyback yield (%): 0
Retained earnings: -34668784
Capitalized R&D asset: 8670645.74
ROCI (R&D-adjusted, %): -56.09756998843698
Rule of 40 score: 0
Financial ratios for BJDX — quarterly report dated 2024-12-31
Capital expenditures: 1125
Buffett classification: The Gruesome
Stock price: 19.48
Shares outstanding: 1034715
Market cap (USD): 20156248.2
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for BJDX — quarterly report dated 2025-03-31
Total revenue: 0
Operating income: -1888917
Net income: -1864435
Capital expenditures: 0
Operating cash flow: -1184857
Depreciation & amortization: 51893
Net tangible assets: 3866376
Owner earnings: -1812542
Return on net tangible assets (%): -46.8796102603575
Buffett classification: The Gruesome
Stock price: 14.92
Shares outstanding: 1034715
Book value: 3866376
P/B ratio: 3.992872860787466
Market cap (USD): 15437947.8
Debt to equity: 0.048462436141751344
Current ratio: 2.713028328132108
Quick ratio: 2.713028328132108
Free cash flow (dilution-adjusted): -1186169
Buyback yield (%): 0
Retained earnings: -36533219
Capitalized R&D asset: 784800
ROCI (R&D-adjusted, %): -28.775381205318862
Rule of 40 score: 0
Financial ratios for BJDX — quarterly report dated 2025-06-30
Total revenue: 0
Operating income: -1985361
Net income: -1956604
Capital expenditures: 0
Operating cash flow: -2054055
Depreciation & amortization: 38355
Net tangible assets: 5290231
Owner earnings: -1918249
Return on net tangible assets (%): -36.26021245575099
Buffett classification: The Gruesome
Stock price: 6.88
Shares outstanding: 1034715
Book value: 5290231
P/B ratio: 1.3456575336691345
Market cap (USD): 7118839.2
Debt to equity: 0.032506331008986186
Current ratio: 4.561255178601103
Quick ratio: 4.561255178601103
Interest coverage ratio: -8943.067567567568
Free cash flow (dilution-adjusted): -2052492
Buyback yield (%): 0
Retained earnings: -38489823
Capitalized R&D asset: 1415712
ROCI (R&D-adjusted, %): -24.39834302831243
Rule of 40 score: 0
Financial ratios for BJDX — quarterly report dated 2025-09-30
Total revenue: 0
Operating income: -1616947
Net income: -1597632
Capital expenditures: 0
Operating cash flow: -1359793
Depreciation & amortization: 31624
Net tangible assets: 3692782
Owner earnings: -1566008
Return on net tangible assets (%): -42.40726909955692
Buffett classification: The Gruesome
Stock price: 6.08
Shares outstanding: 1034715
Book value: 3692782
P/B ratio: 1.7036118568602208
Market cap (USD): 6291067.2
Debt to equity: 0.04023118613554767
Current ratio: 2.9182879817705953
Quick ratio: 2.9182879817705953
Interest coverage ratio: -8084.735
Free cash flow (dilution-adjusted): -1359976
Buyback yield (%): 0
Retained earnings: -40087455
Capitalized R&D asset: 1640822.32
ROCI (R&D-adjusted, %): -30.68355617999132
Rule of 40 score: 0
Financial ratios for BJDX — annual report dated 2025-12-31
Total revenue: 0
Operating income: -6952972
Net income: -6848483
Capital expenditures: 173735
Operating cash flow: -6053575
Depreciation & amortization: 170681
Net tangible assets: 5975289
Owner earnings: -6851537
Return on net tangible assets (%): -114.66452919683047
Buffett classification: The Gruesome
Stock price: 2.67
Shares outstanding: 1034715
Book value: 5975289
P/B ratio: 0.4623523732492269
Market cap (USD): 2762689.05
Debt to equity: 0.02011802274333509
Current ratio: 4.881716087516318
Quick ratio: 4.881716087516318
Interest coverage ratio: -8287.213349225269
Free cash flow (dilution-adjusted): -6227316
Buyback yield (%): 0
Retained earnings: -41517267
Capitalized R&D asset: 7258276.99
ROCI (R&D-adjusted, %): -60.219470837477196
Rule of 40 score: 0
Financial ratios for BJDX — quarterly report dated 2025-12-31
Total revenue: 0
Operating income: -1461747
Net income: -1429812
Capital expenditures: 173735
Operating cash flow: -1454870
Depreciation & amortization: 48809
Net tangible assets: 5975289
Owner earnings: -1554738
Return on net tangible assets (%): -26.01946115074936
Buffett classification: The Gruesome
Stock price: 2.67
Shares outstanding: 1034715
Book value: 5975289
P/B ratio: 0.4623523732492269
Market cap (USD): 2762689.05
Debt to equity: 0.02011802274333509
Current ratio: 4.881716087516318
Quick ratio: 4.881716087516318
Interest coverage ratio: -7816.828877005348
Free cash flow (dilution-adjusted): -1628679
Buyback yield (%): 0
Retained earnings: -41517267
Capitalized R&D asset: 1406167.0399999998
ROCI (R&D-adjusted, %): -22.00162185402079
Rule of 40 score: 0
Financial ratios for BLCO — annual report dated 2022-12-31
Total revenue: 2770588235.2941175
Gross profit: 1653676470.5882351
Operating income: 161764705.88235292
Net income: 11029411.764705881
Capital expenditures: 128676470.58823529
Operating cash flow: 253676470.5882353
Depreciation & amortization: 278676470.58823526
Net tangible assets: 344117647.0588235
Owner earnings: 161029411.76470587
Return on net tangible assets (%): 46.79487179487179
Capex to operating income (%): 79.54545454545455
Buffett classification: The Gruesome
Stock price: 15.51
P/E ratio: 501.37568807392
Shares outstanding: 356536358
Book value: 5221323529.411764
P/B ratio: 1.059095243079679
Market cap (USD): 5529878912.58
Debt to equity: 0.34305027460921
Current ratio: 1.6489197530864197
Quick ratio: 1.1643518518518519
Effective tax rate (%): 79.45205479452055
Interest coverage ratio: 1.5068493150684932
COGS to revenue (%): 40.31316348195329
R&D to revenue (%): 8.147558386411891
SG&A to revenue (%): 39.22505307855626
Free cash flow (dilution-adjusted): 79411764.70588234
Buyback yield (%): 0
Retained earnings: 4411764.705882353
Inventory turnover: 2.4187898089171975
Receivables turnover: 5.204419889502762
Capitalized R&D asset: 225735294.11764705
ROCI (R&D-adjusted, %): 4.181848022320697
FCF margin (%): 2.8662420382165603
Rule of 40 score: 2.8662420382165603
Financial ratios for BLCO — annual report dated 2023-12-31
Total revenue: 3140909090.909091
Gross profit: 1896969696.969697
Operating income: 154545454.54545453
Net income: -187878787.87878788
Capital expenditures: 137121212.12121212
Operating cash flow: -12878787.878787879
Depreciation & amortization: 289393939.3939394
Net tangible assets: -995454545.4545454
Owner earnings: -35606060.606060624
Capex to operating income (%): 88.72549019607844
Buffett classification: The Gruesome
Stock price: 17.06
Shares outstanding: 356536358
Book value: 5242424242.424241
P/B ratio: 1.160247623276532
Market cap (USD): 6082510267.48
Debt to equity: 0.6592485549132949
Current ratio: 1.7365421152628244
Quick ratio: 1.0854971500949968
Interest coverage ratio: 0.7208480565371025
COGS to revenue (%): 39.60443801254221
R&D to revenue (%): 7.814761215629522
SG&A to revenue (%): 41.871683550410026
Free cash flow (dilution-adjusted): -206060606.06060606
Buyback yield (%): 0
Retained earnings: -192424242.4242424
Inventory turnover: 1.5972762645914398
Receivables turnover: 4.941597139451728
Capitalized R&D asset: 396697192.51336896
ROCI (R&D-adjusted, %): 2.588889827861741
Rosenberg metric: 1.0777810680090818
FCF margin (%): -6.560540279787746
Revenue growth (%): 13.36614553175064
Rule of 40 score: 6.805605251962893
Financial ratios for BLCO — quarterly report dated 2024-09-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 19.29
Shares outstanding: 356536358
Market cap (USD): 6877586345.82
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for BLCO — quarterly report dated 2024-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 18.06
Shares outstanding: 356536358
Market cap (USD): 6439046625.48
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for BLCO — annual report dated 2024-12-31
Total revenue: 5239160839.160839
Gross profit: 2041258741.2587414
Operating income: 144055944.05594406
Net income: -213286713.2867133
Capital expenditures: 203496503.4965035
Operating cash flow: 162237762.23776224
Depreciation & amortization: 304895104.8951049
Net tangible assets: -1079720279.7202797
Owner earnings: -111888111.88811192
Capex to operating income (%): 141.2621359223301
Buffett classification: The Gruesome
Stock price: 18.06
Shares outstanding: 356536358
Book value: 4576223776.223776
P/B ratio: 1.40706550648478
Market cap (USD): 6439046625.48
Debt to equity: 0.7310513447432764
Current ratio: 1.6041426927502875
Quick ratio: 1.0080552359033372
Interest coverage ratio: 0.5162907268170426
COGS to revenue (%): 24.986652429257877
R&D to revenue (%): 4.578216764548852
SG&A to revenue (%): 27.789642285104115
Free cash flow (dilution-adjusted): -105594405.59440559
Buyback yield (%): 0
Retained earnings: -399300699.3006993
Inventory turnover: 1.806949806949807
Receivables turnover: 7.30214424951267
Capitalized R&D asset: 478807332.3735089
ROCI (R&D-adjusted, %): 1.691940605653619
Rosenberg metric: 0.5878442545109216
FCF margin (%): -2.0154831820608647
Revenue growth (%): 66.80396304130024
Rule of 40 score: 64.78847985923937
Financial ratios for BLCO — quarterly report dated 2025-03-31
Total revenue: 795104895.1048951
Gross profit: 458041958.04195803
Operating income: -42657342.65734266
Net income: -147552447.55244756
Capital expenditures: 76923076.92307693
Operating cash flow: -17482517.482517485
Depreciation & amortization: 74125874.12587413
Net tangible assets: -1141958041.958042
Owner earnings: -150349650.34965035
Buffett classification: The Gruesome
Stock price: 14.5
Shares outstanding: 356536358
Book value: 4498601398.601399
P/B ratio: 1.149196546421576
Market cap (USD): 5169777191
Debt to equity: 0.7506606559925384
Current ratio: 1.5608342989571264
Quick ratio: 0.9634994206257245
Interest coverage ratio: -0.648936170212766
COGS to revenue (%): 42.39226033421284
R&D to revenue (%): 7.563764291996483
SG&A to revenue (%): 49.51627088830255
Free cash flow (dilution-adjusted): -113986013.986014
Buyback yield (%): 0
Retained earnings: -547552447.5524476
Inventory turnover: 0.46750727449078566
Receivables turnover: 1.1290963257199602
Capitalized R&D asset: 60139860.139860146
ROCI (R&D-adjusted, %): -0.0311050786110168
FCF margin (%): -14.335971855760773
Rule of 40 score: -14.335971855760773
Financial ratios for BLCO — quarterly report dated 2025-06-30
Total revenue: 932846715.3284671
Gross profit: 549635036.4963503
Operating income: 8029197.080291971
Net income: -42335766.42335766
Capital expenditures: 64963503.64963503
Operating cash flow: 25547445.255474452
Depreciation & amortization: 78102189.7810219
Net tangible assets: -1159124087.591241
Owner earnings: -29197080.291970797
Capex to operating income (%): 809.090909090909
Buffett classification: The Gruesome
Stock price: 13.01
Shares outstanding: 356536358
Book value: 4750364963.50365
P/B ratio: 0.9764592938052551
Market cap (USD): 4638538017.58
Debt to equity: 0.7619852489244007
Current ratio: 1.5467391304347824
Quick ratio: 0.9755434782608694
Interest coverage ratio: 0.0859375
COGS to revenue (%): 41.07981220657277
R&D to revenue (%): 7.511737089201878
SG&A to revenue (%): 45.305164319248824
Free cash flow (dilution-adjusted): -61313868.61313868
Buyback yield (%): 0
Retained earnings: -616788321.1678832
Inventory turnover: 0.49952426260704097
Receivables turnover: 1.1789667896678968
Capitalized R&D asset: 110366698.99443622
ROCI (R&D-adjusted, %): 0.39146288646008753
Rosenberg metric: 1.5230011882532664
FCF margin (%): -6.572769953051644
Revenue growth (%): 17.32372936848795
Rule of 40 score: 10.750959415436306
Financial ratios for BLCO — quarterly report dated 2025-09-30
Total revenue: 921582733.8129497
Gross profit: 554676258.9928058
Operating income: 57553956.83453238
Net income: -17985611.51079137
Capital expenditures: 53237410.07194245
Operating cash flow: 98561151.0791367
Depreciation & amortization: 78417266.18705037
Net tangible assets: -1119424460.4316547
Owner earnings: 7194244.604316555
Capex to operating income (%): 92.5
Buffett classification: The Gruesome
Stock price: 15.07
Shares outstanding: 356536358
Book value: 4676258992.805757
P/B ratio: 1.1489960079897534
Market cap (USD): 5373002915.06
Debt to equity: 0.7615384615384615
Current ratio: 1.505801687763713
Quick ratio: 0.9757383966244725
Interest coverage ratio: 0.7920792079207921
COGS to revenue (%): 39.81264637002342
R&D to revenue (%): 7.41608118657299
SG&A to revenue (%): 41.21779859484778
Free cash flow (dilution-adjusted): 25899280.575539574
Buyback yield (%): 0
Retained earnings: -628057553.9568346
Inventory turnover: 0.5074626865671642
Receivables turnover: 1.1763085399449036
Capitalized R&D asset: 135140382.6966501
ROCI (R&D-adjusted, %): 0.6846126561377588
Rosenberg metric: 0.07194244604316775
FCF margin (%): 2.810304449648713
Revenue growth (%): -1.207484716452186
Rule of 40 score: 1.6028197331965268
Financial ratios for BLCO — quarterly report dated 2025-12-31
Total revenue: 3438686131.386861
Gross profit: 636496350.3649634
Operating income: 115328467.15328467
Net income: -42335766.42335766
Capital expenditures: 55474452.55474452
Operating cash flow: 99270072.99270073
Depreciation & amortization: 72262773.72262773
Net tangible assets: -1161313868.6131387
Owner earnings: -25547445.25547445
Capex to operating income (%): 48.101265822784804
Buffett classification: The Good
Stock price: 17.08
Shares outstanding: 356536358
Book value: 4758394160.583941
P/B ratio: 1.279768087537475
Market cap (USD): 6089640994.639999
Debt to equity: 0.7795674183156925
Current ratio: 1.5505208333333336
Quick ratio: 1.0421875000000003
Effective tax rate (%): 546.1538461538461
Interest coverage ratio: 1.612244897959184
COGS to revenue (%): 11.313946083634049
R&D to revenue (%): 1.9953300785395884
SG&A to revenue (%): 11.97198047123753
Free cash flow (dilution-adjusted): -2919708.029197082
Buyback yield (%): 0
Retained earnings: -679562043.7956204
Inventory turnover: 0.5461065573770492
Receivables turnover: 3.858312858312858
Capitalized R&D asset: 137528593.1838471
ROCI (R&D-adjusted, %): 1.281125544506405
Rosenberg metric: 1.1971571263926213
FCF margin (%): -0.08490766291657828
Revenue growth (%): 273.1283155837421
Rule of 40 score: 273.04340792082553
Financial ratios for BLCO — annual report dated 2025-12-31
Total revenue: 6126277372.2627735
Gross profit: 2227007299.270073
Operating income: 137226277.37226278
Net income: -256934306.56934306
Capital expenditures: 254744525.54744524
Operating cash flow: 206569343.0656934
Depreciation & amortization: 307299270.0729927
Net tangible assets: -1161313868.6131387
Owner earnings: -204379562.04379562
Capex to operating income (%): 185.63829787234042
Buffett classification: The Gruesome
Stock price: 17.08
Shares outstanding: 356536358
Book value: 4758394160.583941
P/B ratio: 1.279768087537475
Market cap (USD): 6089640994.639999
Debt to equity: 0.7795674183156925
Current ratio: 1.5505208333333336
Quick ratio: 1.0421875000000003
Interest coverage ratio: 0.4465558194774347
COGS to revenue (%): 24.425116168235434
R&D to revenue (%): 4.420350291909925
SG&A to revenue (%): 26.617419277969734
Free cash flow (dilution-adjusted): -156934306.56934306
Buyback yield (%): 0
Retained earnings: -679562043.7956204
Inventory turnover: 2.1004098360655736
Receivables turnover: 6.873873873873874
Capitalized R&D asset: 512509213.41432285
ROCI (R&D-adjusted, %): 1.6690408991918526
Rosenberg metric: 0.7744036092017612
FCF margin (%): -2.561658524961277
Revenue growth (%): 16.93241647538396
Rule of 40 score: 14.370757950422682
Financial ratios for CHM.AX — annual report dated 2021-06-30
Capital expenditures: 12225.563909774435
Buffett classification: The Gruesome
Stock price: 20.015037593984964
Shares outstanding: 59459543
Market cap (USD): 1190084988.4661655
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CHM.AX — annual report dated 2022-06-30
Operating income: -11854964.827586208
Net income: -10085291.034482758
Capital expenditures: 8475.172413793103
Depreciation & amortization: 655008.275862069
Net tangible assets: 8807242.068965517
Owner earnings: -9438757.931034481
Return on net tangible assets (%): -107.17041563208834
Buffett classification: The Gruesome
Stock price: 6.041379310344827
Shares outstanding: 59459543
Book value: 18229239.310344826
P/B ratio: 19.705575573793023
Market cap (USD): 359217652.8827586
Debt to equity: 0
Current ratio: 2.4437089637216363
Quick ratio: 2.4437089637216363
Interest coverage ratio: -26.853575931026185
Free cash flow (dilution-adjusted): -9425951.724137932
Buyback yield (%): 0.25124792429014914
Retained earnings: -20406342.068965517
Capitalized R&D asset: 3568340.6896551726
ROCI (R&D-adjusted, %): -43.05735109559269
Rule of 40 score: 0
Financial ratios for CHM.AX — annual report dated 2023-06-30
Operating income: -19527946.357615896
Net income: -16887671.52317881
Capital expenditures: 74300
Depreciation & amortization: 639305.298013245
Net tangible assets: -4570469.5364238415
Owner earnings: -16322666.225165563
Buffett classification: The Gruesome
Stock price: 2.3973509933774837
Shares outstanding: 59459543
Book value: 4024650.3311258275
P/B ratio: 35.418081758408704
Market cap (USD): 142545394.4768212
Debt to equity: 0
Current ratio: 0.6578315041088331
Quick ratio: 0.6578315041088331
Interest coverage ratio: -38.10478713437446
Free cash flow (dilution-adjusted): -10872811.920529801
Buyback yield (%): 0.04126441967291276
Retained earnings: -37327356.29139073
Capitalized R&D asset: 11314581.63955241
ROCI (R&D-adjusted, %): -88.54616246043511
Rule of 40 score: 0
Financial ratios for CHM.AX — annual report dated 2024-06-30
Operating income: -14013184
Net income: -8353232.666666667
Capital expenditures: 0
Depreciation & amortization: 670752.6666666666
Net tangible assets: -6360202.666666667
Owner earnings: -7682480
Buffett classification: The Gruesome
Stock price: 1.2666666666666666
Shares outstanding: 59459543
Book value: -749604
Market cap (USD): 75315421.13333333
Debt to equity: -3.1967758976739717
Current ratio: 0.2353366560427514
Quick ratio: 0.2353366560427514
Interest coverage ratio: -63.34864124456392
Free cash flow (dilution-adjusted): -5025149.333333333
Buyback yield (%): 1.0589960479957201
Retained earnings: -44373038
Capitalized R&D asset: 13283272.65716678
ROCI (R&D-adjusted, %): -98.29093778312289
Rule of 40 score: 0
Financial ratios for COSH.OL — quarterly report dated 2025-03-31
Total revenue: 132313043.47826086
Gross profit: -7947826.0869565215
Operating income: -9830434.782608695
Net income: -25618478.260869563
Capital expenditures: 38592391.30434783
Operating cash flow: 35722826.08695652
Depreciation & amortization: 63582608.69565217
Owner earnings: -628260.8695652187
Buffett classification: The Gruesome
Stock price: 8.672709923664122
Shares outstanding: 84439906
Market cap (USD): 732322810.7194656
Interest coverage ratio: -0.5624378109452737
COGS to revenue (%): 106.0068349106204
SG&A to revenue (%): 0.2998488433228181
Free cash flow (dilution-adjusted): -2869565.217391304
Buyback yield (%): 0
Capitalized R&D asset: 0
FCF margin (%): -2.168769716088328
Revenue growth (%): -9.302152305544945
Rule of 40 score: -11.470922021633273
Financial ratios for COSH.OL — annual report dated 2025-12-31
Total revenue: 702560000
Gross profit: 48788235.29411765
Operating income: 34129411.76470588
Net income: -161748235.29411766
Capital expenditures: 206023529.4117647
Operating cash flow: 326035294.11764705
Depreciation & amortization: 263795294.11764705
Net tangible assets: 2010769411.764706
Owner earnings: -103976470.58823532
Return on net tangible assets (%): -5.170979326614221
Capex to operating income (%): 603.653912443985
Buffett classification: The Gruesome
Stock price: 11.804780876494025
Shares outstanding: 84439906
Book value: 2010769411.764706
P/B ratio: 0.4957279446015339
Market cap (USD): 996794587.561753
Debt to equity: 0.48885940061574323
Current ratio: 1.4672418906731393
Quick ratio: 1.4672418906731393
Interest coverage ratio: 0.450710790025635
COGS to revenue (%): 93.05564858601149
SG&A to revenue (%): 1.4031039425562983
Free cash flow (dilution-adjusted): 120011764.70588236
Buyback yield (%): 0
Retained earnings: -85554117.64705883
Receivables turnover: 5.151355174852923
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 1.2043321083824172
FCF margin (%): 17.08206625852345
Revenue growth (%): 19.685692179924885
Rule of 40 score: 36.76775843844834
Financial ratios for CREDITACC.NS — annual report dated 2022-03-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 11.11723592245813
Shares outstanding: 160196031
Market cap (USD): 1780937070.4684162
Buyback yield (%): 0
Retained earnings: 157553738.62587366
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CREDITACC.NS — annual report dated 2023-03-31
Total revenue: 401580998.78197324
Gross profit: 217628501.8270402
Operating income: 172337393.4226553
Net income: 100616321.55907431
Capital expenditures: 1665042.6309378808
Operating cash flow: -400704019.4884288
Depreciation & amortization: 6070645.554202192
Net tangible assets: 560393422.6552985
Owner earnings: 105021924.48233864
Return on net tangible assets (%): 18.740748951819565
Capex to operating income (%): 0.9661528458042676
Buffett classification: The Great
Stock price: 11.059683313032888
P/E ratio: 17.60864781589715
Shares outstanding: 160196031
Book value: 622042630.9378808
P/B ratio: 2.8482249973663443
Market cap (USD): 1771717370.8647993
Debt to equity: 3.194117059626353
Current ratio: 1.5692424462949888
Quick ratio: 1.5692424462949888
Effective tax rate (%): 25.27184237665322
Interest coverage ratio: 8.916062763879262
COGS to revenue (%): 45.807071926429636
SG&A to revenue (%): 1.4009790778227347
Free cash flow (dilution-adjusted): -404110840.4384897
Buyback yield (%): 0
Retained earnings: 225959805.11571255
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 10.44613252632224
FCF margin (%): -100.6299704578129
Rule of 40 score: -100.6299704578129
Financial ratios for CREDITACC.NS — annual report dated 2024-03-31
Total revenue: 588196426.4300276
Gross profit: 336175800.45569015
Operating income: 282182515.8891953
Net income: 173393692.2892433
Capital expenditures: 1418635.3279769756
Operating cash flow: -567667586.0414917
Depreciation & amortization: 6133828.996282528
Net tangible assets: 728829595.8748051
Owner earnings: 178108885.95754886
Return on net tangible assets (%): 24.437658262733823
Capex to operating income (%): 0.5027367920038077
Buffett classification: The Great
Stock price: 17.155230326295584
P/E ratio: 15.849479717976314
Shares outstanding: 160196031
Book value: 787861853.9393215
P/B ratio: 3.4881747293924
Market cap (USD): 2748199809.1633873
Debt to equity: 3.3243647621453936
Current ratio: 1.769860381194857
Quick ratio: 1.769860381194857
Effective tax rate (%): 25.436009034746647
Interest coverage ratio: 10.801560706908424
COGS to revenue (%): 42.846337490341426
SG&A to revenue (%): 0.9918511224329608
Free cash flow (dilution-adjusted): -572106967.2622617
Buyback yield (%): 0
Retained earnings: 361082863.65271616
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 12.616683627457393
FCF margin (%): -97.26461120047625
Revenue growth (%): 46.47018365263138
Rule of 40 score: -50.794427547844876
Financial ratios for CREDITACC.NS — quarterly report dated 2024-09-30
Capital expenditures: 0
Net tangible assets: 776801242.2360249
Buffett classification: The Gruesome
Stock price: 14.304825609173434
Shares outstanding: 160196031
Book value: 834736024.8447208
P/B ratio: 2.74527062272534
Market cap (USD): 2291576286.7367415
Debt to equity: 2.7407765142571763
Current ratio: 87.72179093699224
Quick ratio: 87.72179093699224
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CREDITACC.NS — quarterly report dated 2024-12-31
Total revenue: 158952092.31845203
Gross profit: 82734584.45040214
Operating income: 70480242.45250028
Net income: -11600419.629327426
Capital expenditures: 0
Depreciation & amortization: 1810234.2930411468
Owner earnings: -9790185.336286278
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 10.333955006411003
Shares outstanding: 160196031
Market cap (USD): 1655458576.5596223
COGS to revenue (%): 47.949987166795
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0